ETF Securities CURE ETF (ASX:CURE)

The ETFS CURE ETF provides investors with exposure to the US biotechnology sub-industry within the health care sector. CURE adopts an equally weighted strategy, which allocates greater exposure to small and mid-cap shares compared to a market capitalisation weighted approach.

CURE share price & data

Ticker code: CURE
Yearly fee (MER): 0.45%
FUM: $8.84 million
Monthly spread: 0.87%
Oct
2019
Apr
Jul
Oct
2020
Apr
Jul
Oct
2019
Apr
Jul
Oct
2020
Apr
Jul
Oct
2019
Apr
Jul
Oct
2020
Apr
Jul
Oct
2019
Apr
Jul
Oct
2020
Apr
Jul
$25.00
$27.50
$30.00
$32.50
$35.00
$37.50
$40.00
$42.50
$25.00
$27.50
$30.00
$32.50
$35.00
$37.50
$40.00
$42.50
$25.00
$27.50
$30.00
$32.50
$35.00
$37.50
$40.00
$42.50
$25.00
$27.50
$30.00
$32.50
$35.00
$37.50
$40.00
$42.50
Range: 1 mth | 3 mths | 6 mths | 1 yr | 2 yrs | 5 yrs | 10 yrs

Prices updated using end of day data. Capital return only. FUM, fee and spread data updated monthly. Last updated: July 2020.

What does the CURE invest in?

The CURE ETF invests in biotechnology stocks trading on major US exchanges. CURE tracks the performance of the S&P Biotechnology Select Industry Index by holding all of the shares that make up the index, closely in proportion to their index weights. These companies are classified as belonging to the GICS biotechnology sub-industry, and must meet certain market capitalisation and liquidity requirements.

What do investors use CURE for?

CURE could be used by investors to get tactical exposure to a basket of companies within the USA’s biotechnology industry. Most biotech companies are heavily research-focused and their success can often depend on one breakthrough or regulatory approval, making it a speculative industry.

CURE dividend information

Fund Issuer

ETF Securities is Australia’s second-oldest ETF business. Founded by Graham Tuckwell in 2003, ETF Securities has grown to become one of the leaders in the Australian ETF market.

Best ETFs warnings

The following warnings are applied by our team, based on quantitative metrics and our internal methodology. These risks are not exhaustive and therefore they should not be relied upon. Always read the PDS of the function and speak to your financial adviser before acting on this information.

When an ETF does not have a sufficiently long track record — typically, we consider this to be at least 3 years — the ETF is could be at a higher risk of being closed down (if it doesn’t grow), and the historical performance and returns (if any) cannot be relied upon.

Tax Domicile

When a fund/ETF has a “domicile” of Australia it means it is a registered fund in Australia for tax purposes.

Registry

Computershare is not only the largest share registry in Australia but also the world. The company was founded in 1978 as one of Melbourne’s first start-up technology companies, initially providing computer services to businesses.

Sector Information

The Best ETFs global or international shares sector includes ETFs, managed funds and index funds which cover international equities/share markets.

Looking for something better?

This brilliant (and free!) report is issued by Best ETFs Australia, a division of The Rask Group Pty Ltd. It is not a recommendation.
Speak to a financial professional before relying on this information and please read our Financial Services Guide (FSG).

feedback-icon

What can we do better? Leave us some feedback?

We care about your experience, please let us know if you have any suggestions to improve our site.